triiodothyronine has been researched along with Graves Ophthalmopathy in 24 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
Excerpt | Relevance | Reference |
---|---|---|
"Triiodothyronine (T3) levels were higher in GO patients than in those without GO." | 5.40 | Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy. ( Koh, DG; Lee, JH; Park, SH; Suh, BK, 2014) |
"0 mL, but we observed severe hyperthyroidism with elevated serum free triiodothyronine, free thyroxine, and thyrotropin receptor antibody levels." | 3.78 | Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule. ( Le Moli, R; Muscia, V; Pezzino, V; Regalbuto, C; Russo, M; Vigneri, R, 2012) |
"Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
"Hyperthyroidism is a significant contributor to oxidative stress in patients with active TAO, which manifests as upregulated lipid peroxidation and antioxidant system activation." | 1.56 | The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy. ( Kos-Kudła, B; Londzin-Olesik, M; Nowak, A; Nowak, M; Wielkoszyński, T, 2020) |
"Triiodothyronine (T3) levels were higher in GO patients than in those without GO." | 1.40 | Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy. ( Koh, DG; Lee, JH; Park, SH; Suh, BK, 2014) |
"Prednisone was started 1 d after RAI and withdrawn after 6 wk." | 1.36 | Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. ( Bartalena, L; Compri, E; Lai, A; Marino, F; Piantanida, E; Sassi, L; Sivelli, P; Tanda, ML, 2010) |
"Cataract surgery may lead to recrudescence of TAO in predisposed individuals." | 1.35 | Reactivation of thyroid-associated orbitopathy after cataract surgery. ( Douglas, RS; Goldberg, RA; Menghani, RM; Shadpour, JM; Tsirbas, A, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 14 (58.33) | 24.3611 |
2020's | 6 (25.00) | 2.80 |
Authors | Studies |
---|---|
Nakano, M | 1 |
Konishi, H | 1 |
Koshiba, M | 1 |
Zhou, J | 1 |
Yu, X | 1 |
Lou, Y | 1 |
Bao, J | 1 |
Xia, Y | 1 |
Zhu, L | 1 |
Liu, R | 1 |
Ye, Z | 1 |
Liu, Q | 1 |
Xuan, M | 1 |
Li, R | 1 |
Zhang, L | 1 |
Zhang, K | 1 |
Fang, P | 1 |
Xue, Y | 1 |
Plazinska, MT | 1 |
Sawicka-Gutaj, N | 2 |
Czarnywojtek, A | 1 |
Wolinski, K | 1 |
Kobylecka, M | 1 |
Karlińska, M | 1 |
Prasek, K | 1 |
Zgorzalewicz-Stachowiak, M | 1 |
Borowska, M | 1 |
Gut, P | 1 |
Ruchala, M | 1 |
Krolicki, L | 1 |
Londzin-Olesik, M | 1 |
Kos-Kudła, B | 1 |
Nowak, A | 1 |
Wielkoszyński, T | 1 |
Nowak, M | 2 |
Van Regemorter, E | 1 |
Joris, V | 1 |
Van Regemorter, V | 1 |
Marique, L | 1 |
Behets, C | 1 |
Lengelé, B | 1 |
Boschi, A | 1 |
Baldeschi, L | 1 |
Daumerie, C | 1 |
Many, MC | 1 |
Craps, J | 1 |
Machen, L | 1 |
MacIntosh, P | 1 |
Bruscolini, A | 1 |
Abbouda, A | 1 |
Locuratolo, N | 1 |
Restivo, L | 1 |
Trimboli, P | 1 |
Romanelli, F | 1 |
Lee, JH | 1 |
Park, SH | 1 |
Koh, DG | 1 |
Suh, BK | 1 |
Erdei, A | 1 |
Paragh, G | 1 |
Kovacs, P | 1 |
Karanyi, Z | 1 |
Berenyi, E | 1 |
Galuska, L | 1 |
Lenkey, A | 1 |
Szabados, L | 1 |
Gyory, F | 1 |
Ujhelyi, B | 1 |
Berta, A | 1 |
Boda, J | 1 |
Berta, E | 1 |
Bodor, M | 1 |
Gazdag, A | 1 |
Nagy, EV | 1 |
Sendhil Kumaran, M | 1 |
Dutta, P | 1 |
Sakia, U | 1 |
Dogra, S | 1 |
Budny, B | 1 |
Zybek-Kocik, A | 1 |
Sowiński, J | 1 |
Ziemnicka, K | 1 |
Waligórska-Stachura, J | 1 |
Ruchała, M | 1 |
Tu, Y | 1 |
Wang, Y | 1 |
Ding, L | 1 |
Zhang, J | 1 |
Wu, W | 1 |
Fernando, R | 1 |
Placzek, E | 1 |
Reese, EA | 1 |
Placzek, AT | 1 |
Schwartz, S | 1 |
Trierweiler, A | 1 |
Niziol, LM | 1 |
Raychaudhuri, N | 1 |
Atkins, S | 1 |
Scanlan, TS | 1 |
Smith, TJ | 1 |
Sieminska, L | 1 |
Niedziolka, D | 1 |
Pillich, A | 1 |
Kos-Kudla, B | 1 |
Marek, B | 1 |
Borgiel-Marek, H | 1 |
Shadpour, JM | 1 |
Menghani, RM | 1 |
Douglas, RS | 1 |
Goldberg, RA | 1 |
Tsirbas, A | 1 |
Daroszewski, J | 1 |
Pawlak, E | 1 |
Karabon, L | 1 |
Frydecka, I | 1 |
Jonkisz, A | 1 |
Slowik, M | 1 |
Bolanowski, M | 1 |
Lai, A | 1 |
Sassi, L | 1 |
Compri, E | 1 |
Marino, F | 1 |
Sivelli, P | 1 |
Piantanida, E | 1 |
Tanda, ML | 1 |
Bartalena, L | 1 |
Akarsu, E | 1 |
Buyukhatipoglu, H | 1 |
Aktaran, S | 1 |
Kurtul, N | 1 |
Regalbuto, C | 1 |
Le Moli, R | 1 |
Muscia, V | 1 |
Russo, M | 1 |
Vigneri, R | 1 |
Pezzino, V | 1 |
Jang, SY | 1 |
Lee, SY | 1 |
Lee, EJ | 1 |
Yoon, JS | 1 |
Subekti, I | 1 |
Boedisantoso, A | 1 |
Moeloek, ND | 1 |
Waspadji, S | 1 |
Mansyur, M | 1 |
Profilo, MA | 1 |
Sisti, E | 1 |
Marcocci, C | 1 |
Vitti, P | 1 |
Pinchera, A | 1 |
Nardi, M | 1 |
Rocchi, R | 1 |
Latrofa, F | 1 |
Menconi, F | 1 |
Altea, MA | 1 |
Leo, M | 1 |
Rago, T | 1 |
Marinò, M | 1 |
Xia, N | 1 |
Zhou, S | 1 |
Liang, Y | 1 |
Xiao, C | 1 |
Shen, H | 1 |
Pan, H | 1 |
Deng, H | 1 |
Wang, N | 1 |
Li, QQ | 1 |
24 other studies available for triiodothyronine and Graves Ophthalmopathy
Article | Year |
---|---|
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
Topics: Autoantibodies; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; | 2022 |
Detection and Correlation Analysis of Serum Uric Acid in Patients with Thyroid-Associated Ophthalmopathy.
Topics: Glycated Hemoglobin; Graves Ophthalmopathy; Humans; Thyroid Hormones; Thyrotropin; Thyroxine; Triiod | 2022 |
MicroRNA-376b is involved in the pathogenesis of thyroid-associated ophthalmopathy by regulating HAS2.
Topics: Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Leukocytes, Mononuclear; MicroRNAs; Triiodothyr | 2023 |
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.
Topics: Adult; Female; Graves Ophthalmopathy; Humans; Hyperthyroidism; Male; Middle Aged; Oxidative Stress; | 2020 |
Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1α Increase, Are Involved in the Oxidative Stress of Graves' Orbital Adipocytes.
Topics: Adipocytes; Adult; Case-Control Studies; Caveolin 1; Cells, Cultured; Female; Gene Expression Regula | 2021 |
Considerations in Pediatric Proptosis.
Topics: Adolescent; Antithyroid Agents; Blepharoptosis; Cholinesterase Inhibitors; Drug Therapy, Combination | 2018 |
Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
Topics: Adult; Dry Eye Syndromes; Female; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulatin | 2015 |
Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy.
Topics: Adolescent; Autoantibodies; Child; Female; Graves Ophthalmopathy; Humans; Iodide Peroxidase; Male; P | 2014 |
Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Female; Follow-Up Studies; Graves Ophthalmopathy; Hum | 2014 |
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination; | 2015 |
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.
Topics: Adult; Autoantibodies; Body Mass Index; Cross-Sectional Studies; Female; Graves Ophthalmopathy; Huma | 2016 |
Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.
Topics: Animals; Body Weight; Disease Models, Animal; Drug Administration Schedule; Endoplasmic Reticulum; G | 2016 |
Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Case-Control Studies; Cells, Cultured; Chromatograp | 2017 |
Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
Topics: Adiponectin; Autoantibodies; Female; Graves Ophthalmopathy; Humans; Male; Middle Aged; Regression An | 2008 |
Reactivation of thyroid-associated orbitopathy after cataract surgery.
Topics: Aged, 80 and over; Cataract Extraction; Female; Graves Ophthalmopathy; Humans; Orbital Diseases; Rec | 2009 |
Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Cohort Studies; CTLA-4 Antigen; DNA; Femal | 2009 |
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
Topics: Adult; Aged; Chi-Square Distribution; Female; Glucocorticoids; Graves Disease; Graves Ophthalmopathy | 2010 |
Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Topics: Adult; Anti-Inflammatory Agents; Female; Glutathione; Graves Ophthalmopathy; Humans; Iodide Peroxida | 2011 |
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule.
Topics: Administration, Cutaneous; Ethanol; Graves Ophthalmopathy; Humans; Hyperthyroidism; Immunoglobulins, | 2012 |
Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients.
Topics: Adult; Euthyroid Sick Syndromes; Eyelid Diseases; Female; Graves Ophthalmopathy; Humans; Hyperthyroi | 2012 |
Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy.
Topics: Adipose Tissue; Adult; Cross-Sectional Studies; Female; Graves Ophthalmopathy; Humans; Immunoglobuli | 2012 |
Thyroid volume and severity of Graves' orbitopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Graves Ophthalmopathy; Humans; M | 2013 |
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Female; | 2006 |